Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease

Several studies have shown decreased cerebral blood flow (CBF) in Alzheimer’s disease (AD). However, the role of hypoperfusion in the disease pathogenesis remains unclear. Combining arterial spin labeling MRI, PET, and CSF biomarkers, we investigated the associations between gray matter (GM)-CBF and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Khazar, Pereira, Joana B, Berron, David, Vogel, Jacob, Ingala, Silvia, Strandberg, Olof T, Janelidze, Shorena, Barkhof, Frederik, Pfeuffer, Josef, Knutsson, Linda, van Westen, Danielle, Palmqvist, Sebastian, Mutsaerts, Henk JMM, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063832/
https://www.ncbi.nlm.nih.gov/pubmed/36412244
http://dx.doi.org/10.1177/0271678X221141139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063832/
https://www.ncbi.nlm.nih.gov/pubmed/36412244
http://dx.doi.org/10.1177/0271678X221141139

Ejemplares similares